Keratosis pilaris. Other specified epidermal thickening
Conditions
Interventions
Intervention 1: Control group receives topical ammonium lactate 14% making the company noreva twice a day used as a thin layer on the waste for 3 months. Intervention 2: In treatment group
Treatment - Other
Control group receives topical ammonium lactate 14% making the company noreva twice a day used as a thin layer on the waste for 3 months.
In treatment group we done 3 IPL sessions with 4 weeks interval and also advised the patients to apply topical ammunium lactate 14% making the company noreva twice a day used as a thin layer on the wa
Sponsors
Vice Chancellor foer research of Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria:being afflicted with keratosis pilaris; patients who don't tend to only longterm and topical treatment and they prefer laser treatmen; no pregnancy and breast feeding and consent to participate in the study. Exclusion criteria:sensitivity to Ammonium lactate; no regular visits and using cotreatments.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical improvment. Timepoint: Before, 1 month after final treatment and 2 month after final treatment. Method of measurement: Photography evaluation by two blinded dermatologist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvements Vas score. Timepoint: Before, 1 month after final treatment and 2 month after final treatment. Method of measurement: Question from patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSiamak Rahmani
Isfahan University of Medical Science
Outcome results
None listed